4.3 Article

Effectiveness of oral bisphosphonates for primary prevention of osteoporotic fractures

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Public, Environmental & Occupational Health

User-only design to assess drug effectiveness in clinical practice: application to bisphosphonates and secondary prevention of fractures

Giovanni Corrao et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2014)

Article Endocrinology & Metabolism

Long-term impact of adherence to oral bisphosphonates on osteoporotic fracture incidence

John S. Sampalis et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2012)

Article Health Care Sciences & Services

External adjustment for unmeasured confounders improved drug-outcome association estimates based on health care utilization data

Giovanni Corrao et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2012)

Article Medicine, General & Internal

Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women

Laura Y. Park-Wyllie et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)

Article Endocrinology & Metabolism

Axial and appendicular bone density predict fractures in older women

Dennis M. Black et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2010)

Article Geriatrics & Gerontology

Prognostic Stratification of Older Persons Based on Simple Administrative Data: Development and Validation of the Silver Code, To Be Used in Emergency Department Triage

Mauro Di Bari et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2010)

Article Endocrinology & Metabolism

Hip fractures in Italy: 2000-2005 extension study

P. Piscitelli et al.

OSTEOPOROSIS INTERNATIONAL (2010)

Article Pharmacology & Pharmacy

Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women

Julie Blouin et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)

Article Health Care Sciences & Services

The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients

Mary E. Charlson et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)

Review Endocrinology & Metabolism

A systematic review of persistence and compliance with bisphosphonates for osteoporosis

J. A. Cramer et al.

OSTEOPOROSIS INTERNATIONAL (2007)

Article Endocrinology & Metabolism

Compliance with osteoporosis drug therapy and risk of fracture

D. Weycker et al.

OSTEOPOROSIS INTERNATIONAL (2007)

Article Endocrinology & Metabolism

Osteoporosis: A still increasing prevalence

JY Reginster et al.

Article Geriatrics & Gerontology

Compliance with drug therapies for the treatment and prevention of osteoporosis

JS McCombs et al.

MATURITAS (2004)

Article Public, Environmental & Occupational Health

Lipid lowering drugs prescription and the risk of peripheral neuropathy:: an exploratory case-control study using automated databases

G Corrao et al.

JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2004)

Article Endocrinology & Metabolism

The impact of compliance with osteoporosis therapy on fracture rates in actual practice

JJ Caro et al.

OSTEOPOROSIS INTERNATIONAL (2004)

Article Public, Environmental & Occupational Health

Sensitivity analysis, Monte Carlo risk analysis, and Bayesian uncertainty assessment

S Greenland

RISK ANALYSIS (2001)

Article Medicine, General & Internal

Effect of risedronate on the risk of hip fracture in elderly women

MR McClung et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)

Article Medicine, General & Internal

Low bone mineral density and risk of fracture in white female nursing home residents

JM Chandler et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)

Article Endocrinology & Metabolism

Risk of mortality following clinical fractures

JA Cauley et al.

OSTEOPOROSIS INTERNATIONAL (2000)